" "
Full Text (PDF)
Original Article

Hyperpara Thyroidism and its Management

S.P. Subashini, Dean, School of Nursing, Galgotia University, Greater Noida 201306, Uttar Pradesh, India. , Simrat Kaur1 , S.P. Subashini2 , Pooja Jain3

Author Information

Licence:



Journal of ENT and Allied Sciences 8(1):p 9-12, . | DOI: N/A
How Cite This Article:

Simrat Kaur, S.P. Subashini, Pooja Jain/Hyperpara Thyroidism and its Management/RFP J ENT Allied Sci 2023;8(1):9–12.
 


Received : N/A         Accepted : N/A          Published : N/A

Abstract

Hyperparathyroidism is an increase in parathyroid hormone (PTH) levels in the blood. This occurs from a disorder either within the parathyroid glands (primary hyperparathyroidism) or as response to external stimuli (secondary hyperparathyroidism). Symptoms of hyperparathyroidism are caused by inappropriately normal or elevated blood calcium leaving the bones and flowing into the blood stream in response to increased production of parathyroid hormone. In healthy people, when blood calcium levels are high, parathyroid hormone levels should be low. With long-standing hyperparathyroidism, the most common symptom is kidney stones. Other symptoms may include bone pain, weakness, depression, confusion, and increased urination. Both primary and secondary may result in osteoporosis (weakening of the bones). In 80% of cases, primary hyperparathyroidism is due to a single benign tumor known as a parathyroid adenoma. Most of the remainder are due to several of these adenomas. Very rarely it may be due to parathyroid cancer. Secondary hyperparathyroidism typically occurs due to vitamin D deficiency, chronic kidney disease, or other causes of low blood calcium. The diagnosis of primary hyperparathyroidism is made by finding elevated calcium and PTH in the blood.


References

No records found.


Funding


Author Information

Authors and Affiliatione

  • S.P. Subashini, Dean, School of Nursing, Galgotia University, Greater Noida 201306, Uttar Pradesh, India.
    ,
  • Simrat Kaur1
    ,
  • S.P. Subashini2
    ,
  • Pooja Jain3
    ,

Conflicts of Interest

Supplementary Information

Below is the link to the supplementary material.


Rights and Permissions



About this article


Cite this article

Simrat Kaur, S.P. Subashini, Pooja Jain/Hyperpara Thyroidism and its Management/RFP J ENT Allied Sci 2023;8(1):9–12.
 


Licence:



Download citation

Received Accepted Published
N/A N/A N/A
DOI: N/A
Keywords Vitamin D; Osteoporosis; Parathoromone; Renal Rickets.

Article Level Metrics

Last Updated

Sunday 08 June 2025, 03:23:36 (IST)


3

Accesses

00
0
00

Citations


22
11
23

View full article metrics including social shares, article views and publishing history


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article




Share